主管单位:中华人民共和国
国家卫生健康委员会
主办单位:
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Ren Yingqi1 Pan Lili2 Du Juan2 Li Taotao2
单位:1首都医科大学第六临床医学院,北京100029;2首都医科大学附属北京安贞医院风湿免疫科,北京100029
英文单位:1The Sixth Clinical Medical College Capital Medical University Beijing 100029 China; 2Department of Rheumatology and Immunology Beijing Anzhen Hospital Capital Medical University Beijing 100029 China
英文关键词:Takayasuarteritis;Coronaryartery;Diagnosis;Treatment;Progress
大动脉炎是一种慢性、肉芽肿性大血管炎,主要累及主动脉及其分支,主动脉的二级分支如肺动脉和冠状动脉也可能受累。在大动脉炎患者中,冠状动脉受累并不罕见,是导致其预后不良和死亡率高的重要不利因素。目前系统描述大动脉炎冠状动脉受累情况的有关文献报道较少。本文总结了大动脉炎累及冠状动脉的发病机制、危险因素、临床特征、实验室及影像学特点、与冠状动脉粥样硬化区别和治疗方法,旨在为大动脉炎冠状动脉病变的诊断、防治和改善预后提供依据。
Takayasu arteritis (TAK) is a chronic, granulomatous, large-vessel vasculitis mainly affecting the aorta and its major branches. The secondary branches of the aorta, such as the pulmonary artery and coronary artery, can also be involved. Coronary involvement is not rare in patients with TAK and it is a serious adverse factor associated with a poor prognosis and increased mortality in patients with TAK. At present, the systematic description of coronary artery involvement with TAK is rarely reported. This paper summarizes the pathogenesis, risk factors, clinical features, laboratory and imaging features, the difference between TAK and coronary atherosclerosis and the treatment of coronary artery involvement in patient with TAK. In order to provide evidence for the diagnosis, prevention and treatment of coronary artery involvement in TAK.
copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。